NO20014228L - Radioaktiv cisplatin i behandling av cancer - Google Patents

Radioaktiv cisplatin i behandling av cancer

Info

Publication number
NO20014228L
NO20014228L NO20014228A NO20014228A NO20014228L NO 20014228 L NO20014228 L NO 20014228L NO 20014228 A NO20014228 A NO 20014228A NO 20014228 A NO20014228 A NO 20014228A NO 20014228 L NO20014228 L NO 20014228L
Authority
NO
Norway
Prior art keywords
cancer
treatment
cisplatin
radioactive
radioactive cisplatin
Prior art date
Application number
NO20014228A
Other languages
English (en)
Other versions
NO20014228D0 (no
Inventor
Stanley E Order
Original Assignee
Isotope Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotope Solutions Inc filed Critical Isotope Solutions Inc
Publication of NO20014228D0 publication Critical patent/NO20014228D0/no
Publication of NO20014228L publication Critical patent/NO20014228L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20014228A 1999-03-19 2001-08-31 Radioaktiv cisplatin i behandling av cancer NO20014228L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/272,549 US6074626A (en) 1998-03-20 1999-03-19 Radioactive cisplatin in the treatment of cancer
PCT/US2000/006546 WO2000056369A1 (en) 1999-03-19 2000-03-14 Radioactive cisplatin in the treatment of cancer

Publications (2)

Publication Number Publication Date
NO20014228D0 NO20014228D0 (no) 2001-08-31
NO20014228L true NO20014228L (no) 2001-08-31

Family

ID=23040266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014228A NO20014228L (no) 1999-03-19 2001-08-31 Radioaktiv cisplatin i behandling av cancer

Country Status (15)

Country Link
US (1) US6074626A (no)
EP (1) EP1176988B1 (no)
JP (1) JP2003512296A (no)
KR (1) KR20010108357A (no)
AU (1) AU782093B2 (no)
CZ (1) CZ20013216A3 (no)
HK (1) HK1045119A1 (no)
HU (1) HUP0200717A3 (no)
IL (1) IL145149A0 (no)
MX (1) MXPA01009458A (no)
NO (1) NO20014228L (no)
NZ (1) NZ513872A (no)
TR (1) TR200102576T2 (no)
WO (1) WO2000056369A1 (no)
ZA (1) ZA200107312B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
US20030082102A1 (en) * 2001-06-25 2003-05-01 Court Wayne S. Radioactive platinum complexes for cancer treatment
CN101062053A (zh) * 2001-09-24 2007-10-31 托斯克公司 减低毒性的顺铂制剂及其使用方法
US20030228253A1 (en) * 2002-06-06 2003-12-11 Aranoff Shraga D. Radiolabelled thioplatin, compositions thereof and methods of cancer treatment
US6751280B2 (en) * 2002-08-12 2004-06-15 Ut-Battelle, Llc Method of preparing high specific activity platinum-195m
US20060052690A1 (en) * 2004-09-08 2006-03-09 Sirohey Saad A Contrast agent imaging-driven health care system and method
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
IL83380A (en) * 1987-07-30 1991-04-15 Teva Pharma Stable aqueous cisplatin solutions
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy
US5844001A (en) * 1993-02-26 1998-12-01 Research Development Foundation Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin

Also Published As

Publication number Publication date
JP2003512296A (ja) 2003-04-02
EP1176988A4 (en) 2003-04-23
US6074626A (en) 2000-06-13
NO20014228D0 (no) 2001-08-31
AU4009400A (en) 2000-10-09
CZ20013216A3 (cs) 2002-01-16
HK1045119A1 (zh) 2002-11-15
MXPA01009458A (es) 2004-10-14
ZA200107312B (en) 2002-05-22
EP1176988A1 (en) 2002-02-06
WO2000056369A1 (en) 2000-09-28
HUP0200717A3 (en) 2004-11-29
NZ513872A (en) 2003-08-29
KR20010108357A (ko) 2001-12-07
EP1176988B1 (en) 2004-11-24
TR200102576T2 (tr) 2002-06-21
AU782093B2 (en) 2005-06-30
IL145149A0 (en) 2002-06-30
HUP0200717A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
ITMI990375A1 (it) Trattamento del cancro co epotiloni
KR100695846B9 (ko) 암 치료
AR028476A1 (es) Tratamiento del cancer
DE60040607D1 (de) Wasserbehandlungseinrichtung
NO20024005L (no) Pteridinforbindelser for behandling av psoriasis
NO20042035L (no) Forbedret anvendelse av antitumorforbindelse i kreftterapi
NO20022245L (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
NO20005179D0 (no) Medikament behandling
NO20020358L (no) Anvendelse av etodolac til behandling av kreft
IL161059A0 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
NO20002804L (no) Konjugater som kan anvendes ved behandling av prostatakreft
NO20014725L (no) Forbedret kreftbehandling med temozolomid
NO20014228D0 (no) Radioaktiv cisplatin i behandling av cancer
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
PT1043025E (pt) Tratamento de carcinoma da celula renal
DK1140147T3 (da) hCG-terapi til behandling af metastatisk brystcancer
EP1225919A4 (en) TREATMENT OF CANCER
PL349955A1 (en) Radioactive cisplatin in the treatment of cancer
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
DE60016194D1 (de) Radioaktives cisplatin zur krebsbehandlung.
SE9903421D0 (sv) Behandlingsförfarande
NO995276D0 (no) Behandlingsbenk
GB9815855D0 (en) Conjugates useful in the treatment of prostate cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application